Plasma Fibrinogen Levels and the Clinical Course of Acute Myocardial Infarction

Crislal, N.; Slonim, A.; Bar-Ilan, I.; Hart, A.
November 1983
Angiology;Nov1983, Vol. 34 Issue 11, p693
Academic Journal
Plasma fibrinogen levels were followed from admission to the coronary care unit up to 3 months after an acute myocardial infarction (AMI) (51 patients at entry - 49 patients at follow-up). Mean initial value as determined within 24 hours of onset of symptoms was 522 mg% ± 205 S.D. Peak value 845 mg% ± 215 S.D. was reached 3-5 days after onset of symptoms. Mean fibrinogen level on a later follow-up was similar to the initial value (521 mg% ± 145 S.D.). Our data confirm that a rise in the plasma fibrinogen level is common after myocardial necrosis. No correlation was found between the maximum peak value and the clinical course of the disease. However, death, reinfarction and cardiogenic shock were more frequent among patients with an initial plasma fibrinogen level higher than 400 mg%. Our findings suggest that the acute increase in fibrinogen following necrosis is less significant to the clinical course than a chronically high plasma fibrinogen level.


Related Articles

  • A History of Streptokinase Use in Acute Myocardial Infarction. Sikri, Nikhil; Bardia, Amit // Texas Heart Institute Journal;2007, Vol. 34 Issue 3, p318 

    A serendipitous discovery by William Smith Tillett in 1933, followed by many years of work with his student Sol Sherry, laid a sound foundation for the use of streptokinase as a thrombolytic agent in the treatment of acute myocardial infarction. The drug found initial clinical application in...

  • Clopidogrel before percutaneous coronary intervention reduced cardiovascular outcome in ST-elevation myocardial infarction.  // ACP Journal Club;Mar/Apr2006, Vol. 144 Issue 2, p29 

    The article reports that clopidogrel pretreatment before percutaneous coronary intervention (PCI) reduced cardiovascular outcome in ST-elevation myocardial infarction (MI). Patients in the clopidogrel group had lower rates of the composite endpoint from PCI to 30 days after randomization,...

  • Value of the myocardial performance index in myocardial infarction. Galiuto, L. // Heart;May2005, Vol. 91 Issue 5, p565 

    The myocardial performance index represents an easy and reproducible parameter of both systolic and diastolic left ventricular function for the risk stratification of patients following acute myocardial infarction

  • No association between scar and characteristics on T-wave alternans in post-myocardial infarction patients with relatively preserved ventricular function presented with non-sustained ventricular tachycardia. Danilowicz-Szymanowicz, Ludmila // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Aug2014, Vol. 14 Issue 5, p448 

    The article comments on a study titled "No association between scar size and characteristics on T-wave alternans in post-myocardial Infarction patients with relatively preserved ventricular function presented with non-sustained ventricular tachycardia" by K. Yalın and colleagues in this...

  • Thrombolysis in the Treatment of Acute Transmural Myocardial Infarction. Smith, Budge; Kennedy, J. Ward // Annals of Internal Medicine;Mar87, Vol. 106 Issue 3, p414 

    Examines the use of thrombolytic agents in a therapeutic program of patient management in acute myocardial infarction. Prevalence of intracoronary thrombi at autopsy; Intracoronary streptokinase as a method of reperfusion of ischemic myocardium; Infusion complications with thrombolytic therapy.

  • Fibrinolytic therapy and bleeding complications: risk predictors from RIKS-HIA. Oldgren, Jonas; Wernroth, Lisa; Stenestrand, Ulf // Heart;Sep2010, Vol. 96 Issue 18, p1451 

    Background Fibrinolytic treatment for ST-elevation myocardial infarction is associated with increased bleeding risk but is still widely used world wide, mainly because of limited access to primary PCI. Objective To analyse contemporary fibrinolytic treatment patterns, in-hospital bleeding risk...

  • Thrombolytic therapy in acute myocardial infarction. Tough, Jackie // Nursing Standard;5/25/2005, Vol. 19 Issue 37, p55 

    This article examines thrombolytic therapy, the first-line treatment for patients presenting with acute myocardial infarction in most UK hospitals. The pharmacology of thrombolytic drugs and reasons for their use are discussed.

  • Drug Therapy.  // Current Medical Literature: Cardiology;2008, Vol. 27 Issue 2, p56 

    The article discusses various research being done on drug therapy. They include the incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome, with reference to a study by P. M. Ho et al in the "Journal of the American Medical...

  • Immediate Angioplasty Compared with the Administration of a Thrombolytic Agent Followed by Conservative Treatment for Myocardial Infarction. Gibbons, Raymond J.; Holmes, David R.; Reeder, Guy S.; Bailey, Kent R.; Hopfenspirger, Mona R.; Gersh, Bernard J. // New England Journal of Medicine;3/11/93, Vol. 328 Issue 10, p685 

    Background: Immediate angioplasty and the administration of a thrombolytic agent followed by conservative treatment are two approaches to the management of acute myocardial infarction, but these methods have not been compared prospectively. Methods: We enrolled 108 patients with acute myocardial...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics